Skip to main content
Equibles

Driehaus Capital Management LLC

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 938206 Chicago, IL
Back to ARQT Full portfolio

Position in ARQT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$23,032,329
-$29,412,914 QoQ
Shares Held
878,426
-60.5% QoQ
Ownership
0.699%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#34
of 271 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority Sole 78% Shared 0% None 22%

Common Shares in ARQT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Driehaus Capital Management LLC holds $3,707,249,767 across 60 Biotechnology names. ARQT ranks #32 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 DFTX
Definium Therapeutics, Inc.
 6,845,276 $322,001,783
2 PRAX
Praxis Precision Medicines, Inc.
 959,048 $321,079,679
3 XENE
Xenon Pharmaceuticals Inc.
 4,418,557 $266,704,100
4 SYRE
Spyre Therapeutics, Inc.
 2,799,166 $248,509,957
5 CRNX
Crinetics Pharmaceuticals, Inc.
 6,463,551 $241,866,078
6 APGE
Apogee Therapeutics, Inc.
 1,740,101 $230,963,605
7 EWTX
Edgewise Therapeutics, Inc.
 4,728,623 $192,123,952
8 SEPN
Septerna, Inc.
 4,433,058 $148,463,112

All Filings in ARQT

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $23,032,329 878,426
2026-03-31 $52,445,243 2,226,029
2025-12-31 $74,413,402 2,562,445
2025-09-30 $20,678,525 1,097,004
2025-06-30 $15,225,075 1,085,954
2025-03-31 $17,090,375 1,092,735
2024-12-31 $15,277,992 1,096,769